Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases
NCT05466812
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Thyroid Neoplasm Follicular
Bone Metastases
Interventions
DRUG:
Sr-89
Sponsor
Peking Union Medical College Hospital